APO RESEARCH · REPORT
Amebocyte Lysate
Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.
Product & engineering
Understand the product.
Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.
Selected research
Industry Research
Amebocyte Lysate Industry Research Report 2026
Market perspective
Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.
Zhanjiang A&C, Xiamen Bioendo, Zhanjiang Bokang and Fuzhou Xinbei are the top 4 of Amebocyte Lysate, with about 45% market shares.
Europe is the largest supplier of Amebocyte Lysate, with a production market share nearly 50%. United States is the second largest supplier of Amebocyte Lysate, enjoying production market share nearly 25%.
Read the full market overview
United States is the largest consumption place, with a consumption market share nearly 36%. Following United States, Europe is the second largest consumption place with the consumption market share of 24%.
Report Scope
This report quantifies the global Amebocyte Lysate market in terms of revenue (US$ million) and, where applicable, sales volume (k doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amebocyte Lysate Market by Company
LONZA
Charles River Laboratories
Associates of Cape Cod
Zhanjiang A&C
Xiamen Bioendo
Zhanjiang Bokang
Fuzhou Xinbei
Amebocyte Lysate Segment by Type
Limulus Amebocyte Lysate
Tachypleus Amebocyte Lysate
Amebocyte Lysate Segment by Application
Drug Testing
Clinical Diagnosis
Others
Amebocyte Lysate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amebocyte Lysate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amebocyte Lysate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amebocyte Lysate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amebocyte Lysate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amebocyte Lysate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amebocyte Lysate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Limulus Amebocyte Lysate
- Tachypleus Amebocyte Lysate
Applications
- Drug Testing
- Clinical Diagnosis
- Others
Companies covered
- LONZA
- Charles River Laboratories
- Associates of Cape Cod
- Zhanjiang A&C
- Xiamen Bioendo
- Zhanjiang Bokang
- Fuzhou Xinbei
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amebocyte Lysate Market Size (2021-2032)
- 2.2.2 Global Amebocyte Lysate Sales (2021-2032)
- 2.2.3 Global Amebocyte Lysate Market Average Price (2021-2032)
- 2.3 Amebocyte Lysate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Limulus Amebocyte Lysate
- 2.3.3 Tachypleus Amebocyte Lysate
- 2.4 Amebocyte Lysate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug Testing
- 2.4.3 Clinical Diagnosis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amebocyte Lysate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amebocyte Lysate Sales (k doses) of Manufacturers (2021-2026)
- 3.3 Global Amebocyte Lysate Revenue of Manufacturers (2021-2026)
- 3.4 Global Amebocyte Lysate Average Price by Manufacturers (2021-2026)
- 3.5 Global Amebocyte Lysate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amebocyte Lysate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amebocyte Lysate, Product Type & Application
- 3.8 Global Manufacturers of Amebocyte Lysate, Established Date
- 3.9 Global Amebocyte Lysate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 LONZA
- 4.1.1 LONZA Company Information
- 4.1.2 LONZA Business Overview
- 4.1.3 LONZA Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 LONZA Amebocyte Lysate Product Portfolio
- 4.1.5 LONZA Recent Developments
- 4.2 Charles River Laboratories
- 4.2.1 Charles River Laboratories Company Information
- 4.2.2 Charles River Laboratories Business Overview
- 4.2.3 Charles River Laboratories Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Charles River Laboratories Amebocyte Lysate Product Portfolio
- 4.2.5 Charles River Laboratories Recent Developments
- 4.3 Associates of Cape Cod
- 4.3.1 Associates of Cape Cod Company Information
- 4.3.2 Associates of Cape Cod Business Overview
- 4.3.3 Associates of Cape Cod Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Associates of Cape Cod Amebocyte Lysate Product Portfolio
- 4.3.5 Associates of Cape Cod Recent Developments
- 4.4 Zhanjiang A&C
- 4.4.1 Zhanjiang A&C Company Information
- 4.4.2 Zhanjiang A&C Business Overview
- 4.4.3 Zhanjiang A&C Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zhanjiang A&C Amebocyte Lysate Product Portfolio
- 4.4.5 Zhanjiang A&C Recent Developments
- 4.5 Xiamen Bioendo
- 4.5.1 Xiamen Bioendo Company Information
- 4.5.2 Xiamen Bioendo Business Overview
- 4.5.3 Xiamen Bioendo Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Xiamen Bioendo Amebocyte Lysate Product Portfolio
- 4.5.5 Xiamen Bioendo Recent Developments
- 4.6 Zhanjiang Bokang
- 4.6.1 Zhanjiang Bokang Company Information
- 4.6.2 Zhanjiang Bokang Business Overview
- 4.6.3 Zhanjiang Bokang Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhanjiang Bokang Amebocyte Lysate Product Portfolio
- 4.6.5 Zhanjiang Bokang Recent Developments
- 4.7 Fuzhou Xinbei
- 4.7.1 Fuzhou Xinbei Company Information
- 4.7.2 Fuzhou Xinbei Business Overview
- 4.7.3 Fuzhou Xinbei Amebocyte Lysate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fuzhou Xinbei Amebocyte Lysate Product Portfolio
- 4.7.5 Fuzhou Xinbei Recent Developments
5 Global Amebocyte Lysate Market Scenario by Region
- 5.1 Global Amebocyte Lysate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amebocyte Lysate Sales by Region: 2021-2032
- 5.2.1 Global Amebocyte Lysate Sales by Region: 2021-2026
- 5.2.2 Global Amebocyte Lysate Sales by Region: 2027-2032
- 5.3 Global Amebocyte Lysate Revenue by Region: 2021-2032
- 5.3.1 Global Amebocyte Lysate Revenue by Region: 2021-2026
- 5.3.2 Global Amebocyte Lysate Revenue by Region: 2027-2032
- 5.4 North America Amebocyte Lysate Market Facts & Figures by Country
- 5.4.1 North America Amebocyte Lysate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amebocyte Lysate Sales by Country (2021-2032)
- 5.4.3 North America Amebocyte Lysate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amebocyte Lysate Market Facts & Figures by Country
- 5.5.1 Europe Amebocyte Lysate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amebocyte Lysate Sales by Country (2021-2032)
- 5.5.3 Europe Amebocyte Lysate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amebocyte Lysate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amebocyte Lysate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amebocyte Lysate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amebocyte Lysate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amebocyte Lysate Market Facts & Figures by Country
- 5.7.1 South America Amebocyte Lysate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amebocyte Lysate Sales by Country (2021-2032)
- 5.7.3 South America Amebocyte Lysate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Amebocyte Lysate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amebocyte Lysate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amebocyte Lysate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amebocyte Lysate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amebocyte Lysate Sales by Type (2021-2032)
- 6.1.1 Global Amebocyte Lysate Sales by Type (2021-2032) & (k doses)
- 6.1.2 Global Amebocyte Lysate Sales Market Share by Type (2021-2032)
- 6.2 Global Amebocyte Lysate Revenue by Type (2021-2032)
- 6.2.1 Global Amebocyte Lysate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amebocyte Lysate Revenue Market Share by Type (2021-2032)
- 6.3 Global Amebocyte Lysate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amebocyte Lysate Sales by Application (2021-2032)
- 7.1.1 Global Amebocyte Lysate Sales by Application (2021-2032) & (k doses)
- 7.1.2 Global Amebocyte Lysate Sales Market Share by Application (2021-2032)
- 7.2 Global Amebocyte Lysate Revenue by Application (2021-2032)
- 7.2.1 Global Amebocyte Lysate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amebocyte Lysate Revenue Market Share by Application (2021-2032)
- 7.3 Global Amebocyte Lysate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amebocyte Lysate Value Chain Analysis
- 8.1.1 Amebocyte Lysate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amebocyte Lysate Production Mode & Process
- 8.2 Amebocyte Lysate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amebocyte Lysate Distributors
- 8.2.3 Amebocyte Lysate Customers
9 Global Amebocyte Lysate Analyzing Market Dynamics
- 9.1 Amebocyte Lysate Industry Trends
- 9.2 Amebocyte Lysate Industry Drivers
- 9.3 Amebocyte Lysate Industry Opportunities and Challenges
- 9.4 Amebocyte Lysate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst